Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Anemia

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 83 articles:
HTML format



Single Articles


    July 2022
  1. WU YW, Comstock BA, Gonzalez FF, Mayock DE, et al
    Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.
    N Engl J Med. 2022;387:148-159.
    PubMed     Abstract available


  2. NOTARO R, Luzzatto L
    Breakthrough Hemolysis in PNH with Proximal or Terminal Complement Inhibition.
    N Engl J Med. 2022;387:160-166.
    PubMed    


    June 2022
  3. AL-SAMKARI H, Beynon V, van Beers EJ
    Mitapivat versus Placebo for Pyruvate Kinase Deficiency. Reply.
    N Engl J Med. 2022;386:2539.
    PubMed    


  4. SHAH AJ, Schwartz JD, Segovia JC
    Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
    N Engl J Med. 2022;386:2538-2539.
    PubMed    


    April 2022
  5. DI MEGLIO L, Scott A
    Iris Atrophy in Sickle Cell Disease.
    N Engl J Med. 2022;386:1646.
    PubMed    


  6. AL-SAMKARI H, Galacteros F, Glenthoj A, Rothman JA, et al
    Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
    N Engl J Med. 2022;386:1432-1442.
    PubMed     Abstract available


    February 2022
  7. STEINBERG MH
    Fetal-like Hemoglobin in Sickle Cell Anemia.
    N Engl J Med. 2022;386:689-691.
    PubMed    


  8. KANTER J, Walters MC, Krishnamurti L, Mapara MY, et al
    Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.
    N Engl J Med. 2022;386:617-628.
    PubMed     Abstract available


  9. PAYEN E
    Efficacy and Safety of Gene Therapy for beta-Thalassemia.
    N Engl J Med. 2022;386:488-490.
    PubMed    


  10. LOCATELLI F, Thompson AA, Kwiatkowski JL, Porter JB, et al
    Betibeglogene Autotemcel Gene Therapy for Non-beta(0)/beta(0) Genotype beta-Thalassemia.
    N Engl J Med. 2022;386:415-427.
    PubMed     Abstract available


    January 2022
  11. PATEL A, Tillman BF
    Spur-Cell Hemolytic Anemia.
    N Engl J Med. 2022;386:e6.
    PubMed    


  12. SCHEINBERG P
    A New Standard Immunosuppression Regimen in Severe Aplastic Anemia.
    N Engl J Med. 2022;386:89-90.
    PubMed    


  13. PEFFAULT DE LATOUR R, Kulasekararaj A, Iacobelli S, Terwel SR, et al
    Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
    N Engl J Med. 2022;386:11-23.
    PubMed     Abstract available


    December 2021
  14. WILLETT LL, Bromberg GK, Chung R, Leaf RK, et al
    Case 38-2021: A 76-Year-Old Woman with Abdominal Pain, Weight Loss, and Memory Impairment.
    N Engl J Med. 2021;385:2378-2388.
    PubMed    


  15. GOYAL S, Tisdale J, Schmidt M, Kanter J, et al
    Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease.
    N Engl J Med. 2021 Dec 12. doi: 10.1056/NEJMoa2109167.
    PubMed     Abstract available


  16. PASRICHA SR, Hamadani JD, Biggs BA
    Benefits and Risks of Iron Interventions in Infants in Bangladesh. Reply.
    N Engl J Med. 2021;385:2199.
    PubMed    


  17. TERADA R, Sato T
    Benefits and Risks of Iron Interventions in Infants in Bangladesh.
    N Engl J Med. 2021;385:2198-2199.
    PubMed    


    November 2021
  18. JONASCH E, Donskov F, Iliopoulos O, Rathmell WK, et al
    Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.
    N Engl J Med. 2021;385:2036-2046.
    PubMed     Abstract available


  19. SINGH AK, Carroll K, McMurray JJV, Solomon S, et al
    Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2113380.
    PubMed     Abstract available


  20. PARFREY P
    Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in CKD.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMe2117100.
    PubMed    


  21. SINGH AK, Carroll K, Perkovic V, Solomon S, et al
    Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2113379.
    PubMed     Abstract available


    October 2021
  22. HILLMEN P, Risitano AM, Peffault de Latour R
    Pegcetacoplan versus Eculizumab in PNH. Reply.
    N Engl J Med. 2021;385:1725-1726.
    PubMed    


  23. GURNARI C, Pagliuca S, Maciejewski JP
    Pegcetacoplan versus Eculizumab in PNH.
    N Engl J Med. 2021;385:1725.
    PubMed    


  24. KULASEKARARAJ AG, Gandhi S, Brodsky RA
    Pegcetacoplan versus Eculizumab in PNH.
    N Engl J Med. 2021;385:1724-1725.
    PubMed    


  25. UEDA Y, Takamori H, Nishimura JI
    Pegcetacoplan versus Eculizumab in PNH.
    N Engl J Med. 2021;385:1723-1724.
    PubMed    


  26. CHERTOW GM, Eckardt KU
    Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease. Reply.
    N Engl J Med. 2021;385:e56.
    PubMed    


  27. BUNN HF
    Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease.
    N Engl J Med. 2021;385:e56.
    PubMed    


  28. HOCK H, Kelly HR, Meyerowitz EA, Frigault MJ, et al
    Case 31-2021: A 21-Year-Old Man with Sore Throat, Epistaxis, and Oropharyngeal Petechiae.
    N Engl J Med. 2021;385:1511-1520.
    PubMed    


  29. BERENTSEN S, Barcellini W
    Autoimmune Hemolytic Anemias.
    N Engl J Med. 2021;385:1407-1419.
    PubMed    


    September 2021
  30. PASRICHA SR, Hasan MI, Braat S, Larson LM, et al
    Benefits and Risks of Iron Interventions in Infants in Rural Bangladesh.
    N Engl J Med. 2021;385:982-995.
    PubMed     Abstract available


  31. PICHAN C, Dhaliwal G, Cusick A, Saint S, et al
    Inadequate Support.
    N Engl J Med. 2021;385:938-944.
    PubMed    


    August 2021
  32. GURNARI C, Rogers HJ
    Copper Deficiency.
    N Engl J Med. 2021;385:640.
    PubMed    


    July 2021
  33. AVELAR RODRIGUEZ D, Orkin J
    An Icteric Tongue.
    N Engl J Med. 2021;385:e16.
    PubMed    


  34. PISCHEL L, Geirsson A, Magaldi J, Martinello RA, et al
    A Brewing Back Pain.
    N Engl J Med. 2021;385:66-72.
    PubMed    


    June 2021
  35. FRANGOUL H, Ho TW, Corbacioglu S
    CRISPR-Cas9 Gene Editing for Sickle Cell Disease and beta-Thalassemia. Reply.
    N Engl J Med. 2021;384:e91.
    PubMed    


  36. MEHTA J
    CRISPR-Cas9 Gene Editing for Sickle Cell Disease and beta-Thalassemia.
    N Engl J Med. 2021;384:e91.
    PubMed    


  37. MEISEL R
    CRISPR-Cas9 Gene Editing for Sickle Cell Disease and beta-Thalassemia.
    N Engl J Med. 2021;384:e91.
    PubMed    


  38. TAHER AT, Musallam KM, Cappellini MD
    beta-Thalassemias. Reply.
    N Engl J Med. 2021;384:2166.
    PubMed    


  39. GEORGALAS I, Petrou P, Kanakis M
    beta-Thalassemias.
    N Engl J Med. 2021;384:2165-2166.
    PubMed    


  40. THONG MK, Ngim CF
    beta-Thalassemias.
    N Engl J Med. 2021;384:2165.
    PubMed    


    May 2021
  41. MUSTJOKI S, Young NS
    Somatic Mutations in "Benign" Disease.
    N Engl J Med. 2021;384:2039-2052.
    PubMed    


  42. GIBBONS MD, Mendoza DP, Waheed A, Barshak MB, et al
    Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia.
    N Engl J Med. 2021;384:1849-1857.
    PubMed    


    April 2021
  43. LEVIN A
    Therapy for Anemia in Chronic Kidney Disease - New Interventions and New Questions.
    N Engl J Med. 2021;384:1657-1658.
    PubMed    


  44. ECKARDT KU, Agarwal R, Aswad A, Awad A, et al
    Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
    N Engl J Med. 2021;384:1601-1612.
    PubMed     Abstract available


  45. CHERTOW GM, Pergola PE, Farag YMK, Agarwal R, et al
    Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
    N Engl J Med. 2021;384:1589-1600.
    PubMed     Abstract available


  46. ROTH A, Barcellini W, D'Sa S, Miyakawa Y, et al
    Sutimlimab in Cold Agglutinin Disease.
    N Engl J Med. 2021;384:1323-1334.
    PubMed     Abstract available


    March 2021
  47. HILLMEN P, Szer J, Weitz I, Roth A, et al
    Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.
    N Engl J Med. 2021;384:1028-1037.
    PubMed     Abstract available


  48. OGUNWOLE SM
    Without Sanctuary.
    N Engl J Med. 2021;384:791-793.
    PubMed    


    February 2021
  49. MENON BS, Teh KH
    Gum Hypertrophy from Cyclosporine.
    N Engl J Med. 2021;384:744.
    PubMed    


  50. TAHER AT, Musallam KM, Cappellini MD
    beta-Thalassemias.
    N Engl J Med. 2021;384:727-743.
    PubMed    


    January 2021
  51. MALECH HL
    Treatment by CRISPR-Cas9 Gene Editing - A Proof of Principle.
    N Engl J Med. 2021;384:286-287.
    PubMed    


  52. WALTERS MC
    Induction of Fetal Hemoglobin by Gene Therapy.
    N Engl J Med. 2021;384:284-285.
    PubMed    


  53. ESRICK EB, Lehmann LE, Biffi A, Achebe M, et al
    Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease.
    N Engl J Med. 2021;384:205-215.
    PubMed     Abstract available


  54. FRANGOUL H, Altshuler D, Cappellini MD, Chen YS, et al
    CRISPR-Cas9 Gene Editing for Sickle Cell Disease and beta-Thalassemia.
    N Engl J Med. 2021;384:252-260.
    PubMed     Abstract available


    December 2020
  55. KIRPALANI H, Bell EF, Hintz SR, Tan S, et al
    Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants.
    N Engl J Med. 2020;383:2639-2651.
    PubMed     Abstract available


  56. MENSAH F, Pilichowska M
    Hemophagocytosis of Sickle Cells.
    N Engl J Med. 2020;383:2571.
    PubMed    


  57. KWAMBAI TK, Dhabangi A, Idro R, Opoka R, et al
    Malaria Chemoprevention in the Postdischarge Management of Severe Anemia.
    N Engl J Med. 2020;383:2242-2254.
    PubMed     Abstract available


    November 2020
  58. MALHOTRA R, Namasivayam M, Ghoshhajra BB, Passeri JJ, et al
    Case 36-2020: A 72-Year-Old Woman with Dark Urine and Weakness.
    N Engl J Med. 2020;383:2066-2076.
    PubMed    


  59. POWER-HAYS A, McGann PT
    When Actions Speak Louder Than Words - Racism and Sickle Cell Disease.
    N Engl J Med. 2020;383:1902-1903.
    PubMed    


    August 2020
  60. YOUNG S, Chen L, Palatnick W, Wong P, et al
    Led Astray.
    N Engl J Med. 2020;383:578-583.
    PubMed    


    July 2020
  61. KAPLAN JM
    Roxadustat for Anemia in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:e3.
    PubMed    


  62. XIE J, Chen N
    Roxadustat for Anemia in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:e3.
    PubMed    


  63. SHAH HH, Fishbane S
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    PubMed    


  64. MOHANDAS R, Segal MS
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    PubMed    


  65. ZIELNIOK K, Burdzinska A, Paczek L
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    PubMed    


  66. ANKER MS, Butler J, Anker SD
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    PubMed    


    June 2020
  67. JOHN CC, Opoka RO, Latham TS, Hume HA, et al
    Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa.
    N Engl J Med. 2020;382:2524-2533.
    PubMed     Abstract available


    May 2020
  68. JUUL SE, Comstock BA, Heagerty PJ
    Erythropoietin in Preterm Infants. Reply.
    N Engl J Med. 2020;382:1862-1863.
    PubMed    


  69. EHRENREICH H, Neubauer AP, Miskowiak K
    Erythropoietin in Preterm Infants.
    N Engl J Med. 2020;382:1862.
    PubMed    


    March 2020
  70. CAPPELLINI MD, Viprakasit V, Taher AT, Georgiev P, et al
    A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent beta-Thalassemia.
    N Engl J Med. 2020;382:1219-1231.
    PubMed     Abstract available


    February 2020
  71. ARAUJO PEREIRA J, Sousa Gomes M
    Twin Anemia Polycythemia Sequence.
    N Engl J Med. 2020;382:e9.
    PubMed    


    January 2020
  72. JUUL SE, Comstock BA, Wadhawan R, Mayock DE, et al
    A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.
    N Engl J Med. 2020;382:233-243.
    PubMed     Abstract available


  73. FENAUX P, Platzbecker U, Mufti GJ, Garcia-Manero G, et al
    Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
    N Engl J Med. 2020;382:140-151.
    PubMed     Abstract available


    November 2019
  74. CUMMINGS BM, Shailam R, Rosales AM, Huang MS, et al
    Case 37-2019: A 20-Month-Old Boy with Severe Anemia.
    N Engl J Med. 2019;381:2158-2167.
    PubMed    


  75. BRODSKY RA
    Warm Autoimmune Hemolytic Anemia. Reply.
    N Engl J Med. 2019;381:1881-1882.
    PubMed    


  76. SHVIDEL L, Stanevsky A, Sigler E
    Warm Autoimmune Hemolytic Anemia.
    N Engl J Med. 2019;381:1881.
    PubMed    


    October 2019
  77. MAITLAND K, Olupot-Olupot P, Walker AS
    Transfusion Timing and Volume in African Children with Severe Anemia. Reply.
    N Engl J Med. 2019;381:1687-1688.
    PubMed    


  78. SATO T, Takahashi K, Tasaki T
    Transfusion Timing and Volume in African Children with Severe Anemia.
    N Engl J Med. 2019;381:1686-1687.
    PubMed    


  79. ROBINSON AN, Loh JSP
    Atrophic Glossitis.
    N Engl J Med. 2019;381:1568.
    PubMed    


  80. VALLURUPALLI M, Divakaran S, Parnes A, Levy BD, et al
    The Element of Surprise.
    N Engl J Med. 2019;381:1365-1371.
    PubMed    


    September 2019
  81. VALLURUPALLI M, Vaidya A, Foote M, Jain N, et al
    The Element of Surprise.
    N Engl J Med. 2019;381:e28.
    PubMed    


  82. SHARMA K, Patel A
    Livedo Reticularis in Cold Agglutinin Disease.
    N Engl J Med. 2019;381:e27.
    PubMed    


  83. GRACE RF, Rose C, Layton DM, Galacteros F, et al
    Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.
    N Engl J Med. 2019;381:933-944.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: